Search Results

During that time, I investigated the effect of lung cancer-related mutations in the GAIN domain of the Since beginning her undergraduate studies, she has used computational methods like molecular dynamics GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash Cam Sinh Lu on the web LinkedIn Dr.

<< Back to podcast list Strategic Partner(s) Yao Lu (Jackie) About Yao Lu (Jackie) "Jackie is a Ph.D. small molecules for their pre-clinical efficacy and to support the design of novel therapeutics. " Yao Lu

Lukas Grätz About Dr. Lukas Grätz "After a BSc in biology and a MSc in bioinformatics, I have been working in David Gloriam's My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since In my free time I like to play the guitar, sing and play board games. " Dr. Lukas Grätz on the web Karolinska Institutet ResearchGate PubMed Dr.

My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since In my free time I like to play the guitar, sing and play board games. " Gáspár Pándy-Szekeres on the

development. have been engaged in GPCR cellular and clinical pharmacology as scientist or PI in neonatal lupus Since the creation of Inoviem scientific in Nov. 2011 by myself we have been regularly working with GPCRs

Bob doesn’t really need an introduction since his reputation precedes him. began his career in the late 1960s and has been an Investigator of the Howard Hughes Medical Institute since

LUXendin Family Red and far-red fluorescent GLP-1R antagonists derived from Exendin4(9–39). Since 2020, he leads an independent research group at the FMP Berlin. He is a principal architect of the LUXendin and daLUXendin probe families. Dr.

Since then, he has been studying the allosteric modulation and activation mechanism of this family of

Since then Oliver has worked at the University of Geneva, where his research on peptide engineering and

Since establishing his independent laboratory, his group has made defining contributions to biased agonism

Julia has been working as a researcher in Duke's Rajagopal Lab since her first year as an undergraduate

She has been an undergraduate student member in the Rajagopal Lab since January 2021 and has contributed

Since 2011, Terry works at the Department of Pharmacology at the University of North Carolina School

Since then, Brendan worked as a research assistant at the Victor Chang Cardiac Research Institute where

Instead, she followed it, and the decision has shaped the direction of her lab at Johns Hopkins ever since Matsunami's RTP1S chaperone, the Rho tag, and the Pluznick lab's Lucy tag — a cleavable leucine-rich kidney 19:56 The orthology problem: 1,000 mouse ORs, 350 human ones 23:08 RTP1S, the Rho tag, and the Lucy

Scott Struthers, Ph.D., is our co-founder and has served as our President and Chief Executive Officer since

Since 2019, Nick has combined his university role with the leadership of Excellerate Bioscience as Chief

Aylin Hanyaloglu has been a Principal Investigator at Imperial College London since 2007.

His group contributed to the early cloning of GPCRs in the mid-1980s and has since pushed the boundaries An MD-PhD who has practiced machine learning since 1989, he built Pharos, the public-facing data platform I have learned a lot since." — Dr. Tudor Oprea "Dan Rich worked on HIV protease inhibitors.

This fascination accompanied me and repeatedly challenged me ever since. Since 2014, I have led a research group at the Rudolf Schönheimer Institute of Biochemistry in Leipzig

About this episode GPCRs have played a central role in my scientific career ever since I took Dr. Alexander Hauser , and Luise Wagner .

Since my undergraduate studies, I have been engaged in researching molecular mechanisms that govern human

Since 2013, he has been elected Chair of the subcommittee for the Dopamine receptors of the International

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of

Since then I transitioned into a Scientific Support role to leverage my passion for helping people!

After 7 years at WL/PD and 26 years at Eli Lilly & Co., he retired at the end of 2014 and since then

learning for nearly 10 years, applying it to antibody generation, analysis, and property prediction since

Biochemistry and first came across GPCRs, particularly the receptor family I have been investigating ever since

And since then, my incredible adventure as CEO of this fast-growing company started and is continuing

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of